References |
- Beer, H.-D. et al. (2000) J. Biol. Chem. 275:16091.
- Ornitz, D.M. et al. (1992) Mol. Cell. Bio. 12:240.
- Cuiling, Li. et al. (2005) Dev. 132:4755.
- Kouhara, H. et al. (1991) Biochem. Biophys. Res. Commun. 176:31.
- Turner, N and Grose, R. (2010) Nat. Rev. Cancer 10:116.
- Pantoliano, M.W. et al. (1994) Biochemistry 33:10229.
- Ornitz, D.M. et al. (1996) J. Biol. Chem. 271:15292.
- Guerrini, M. et al. (2007) Curr. Pharm. Des. 13:2045.
|
Alternate Names |
BFGFR, CD331, CD331 antigen, CEK, EC 2.7.10, EC 2.7.10.1, FGF R1, FGFBR, FGFR-1, FGFR1, FLGH3, FLJ99988, FLT2H4, Flt-2, Fms-like tyrosine kinase 2, H2, H5, HBGFR, KAL 2, KAL2, N-SAM, OGD, Proto-oncogene c-Fgr, bFGF-R-1, basic fibroblast growth factor receptor 1, fibroblast growth factor receptor 1, fms-related tyrosine kinase 2, heparin-binding growth factor receptor, hydroxyaryl-protein kinase, soluble FGFR1 variant 1, soluble FGFR1 variant 2
|